{"id":"https://openalex.org/W3029698243","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e21019","title":"Phase I/II study of vorolanib plus nivolumab in patients with thoracic malignancies: immunotherapy (IO) correlatives to differentiate responders from nonresponders.","display_name":"Phase I/II study of vorolanib plus nivolumab in patients with thoracic malignancies: immunotherapy (IO) correlatives to differentiate responders from nonresponders.","publication_year":2020,"publication_date":"2020-05-20","ids":{"openalex":"https://openalex.org/W3029698243","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e21019","mag":"3029698243"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.15_suppl.e21019","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e21019","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.e21019","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113915736","display_name":"Katy Beckermann","orcid":"https://orcid.org/0000-0002-4616-6140","observed_orcids":["https://orcid.org/0000-0002-4616-6140"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katy Beckermann","raw_affiliation_strings":["Vanderbilt University Medical Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University Medical Center, Nashville, TN;","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042973687","display_name":"Christine M. Bestvina","orcid":"https://orcid.org/0000-0001-7189-1590","observed_orcids":["https://orcid.org/0000-0001-7189-1590"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine M. Bestvina","raw_affiliation_strings":["The University of Chicago Medicine, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Chicago Medicine, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075392197","display_name":"Jennifer G. Whisenant","orcid":"https://orcid.org/0000-0002-3435-2464","observed_orcids":["https://orcid.org/0000-0002-3435-2464"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer G. Whisenant","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Nashville, TN;","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012061864","display_name":"Hossein Borghaei","orcid":"https://orcid.org/0000-0002-2577-4454","observed_orcids":["https://orcid.org/0000-0002-2577-4454"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hossein Borghaei","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA;","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015060656","display_name":"Taofeek Kunle Owonikoko","orcid":"https://orcid.org/0000-0002-7724-7728","observed_orcids":["https://orcid.org/0000-0002-7724-7728"]},"institutions":[{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taofeek Kunle Owonikoko","raw_affiliation_strings":["Winship Cancer Institute of Emory University, Atlanta, GA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute of Emory University, Atlanta, GA;","institution_ids":["https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025850464","display_name":"Lynne D. Berry","orcid":"https://orcid.org/0000-0001-7700-2918","observed_orcids":["https://orcid.org/0000-0001-7700-2918"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynne D Berry","raw_affiliation_strings":["Vanderbilt University, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt University, Nashville, TN;","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062656698","display_name":"Yu Shyr","orcid":"https://orcid.org/0000-0003-2086-9670","observed_orcids":["https://orcid.org/0000-0003-2086-9670"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu Shyr","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Nashville, TN;","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115589023","display_name":"Chris Liang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159864","display_name":"Xcovery (United States)","ror":"https://ror.org/05c1g2f47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159864"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris Liang","raw_affiliation_strings":["Xcovery Holdings, Inc., Palm Beach Gardens, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xcovery Holdings, Inc., Palm Beach Gardens, FL;","institution_ids":["https://openalex.org/I4210159864"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028773984","display_name":"Giovanni Selvaggi","orcid":"https://orcid.org/0000-0001-8015-8999","observed_orcids":["https://orcid.org/0000-0001-8015-8999"]},"institutions":[{"id":"https://openalex.org/I4210159864","display_name":"Xcovery (United States)","ror":"https://ror.org/05c1g2f47","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159864"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giovanni Selvaggi","raw_affiliation_strings":["Xcovery Holdings, Palm Beach Gardens, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xcovery Holdings, Palm Beach Gardens, FL;","institution_ids":["https://openalex.org/I4210159864"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035640724","display_name":"Heather A. Wakelee","orcid":"https://orcid.org/0000-0003-1136-980X","observed_orcids":["https://orcid.org/0000-0003-1136-980X"]},"institutions":[{"id":"https://openalex.org/I4390039303","display_name":"Stanford Cancer Institute","ror":"https://ror.org/014qe3j22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I4390039303","https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather A. Wakelee","raw_affiliation_strings":["Stanford Cancer Institute, Stanford, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford Cancer Institute, Stanford, CA;","institution_ids":["https://openalex.org/I4390039303"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062894702","display_name":"Leora Horn","orcid":"https://orcid.org/0000-0003-2070-2547","observed_orcids":["https://orcid.org/0000-0003-2070-2547"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leora Horn","raw_affiliation_strings":["Department of Medicine, Vanderbilt Ingram Cancer Center, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Vanderbilt Ingram Cancer Center, Nashville, TN;","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"15_suppl","first_page":"e21019","last_page":"e21019"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/vegf-inhibition","display_name":"VEGF inhibition","score":0.7509999871253967},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8050000071525574},{"id":"https://openalex.org/keywords/thoracic-tumors","display_name":"thoracic tumors","score":0.7450000047683716},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9810000061988831},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.968999981880188},{"id":"https://openalex.org/keywords/thymic-carcinoma","display_name":"thymic carcinoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/acquired-resistance","display_name":"acquired resistance","score":0.4449999928474426},{"id":"https://openalex.org/keywords/primary-refractory-disease","display_name":"primary refractory disease","score":0.7120000123977661},{"id":"https://openalex.org/keywords/immune-response-biomarkers","display_name":"immune response biomarkers","score":0.46399998664855957},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.5860000252723694},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.7200000286102295},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.8140000104904175},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8834165334701538},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7977273464202881},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6406632661819458},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5403341054916382},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.48831960558891296},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.44612258672714233},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.43969541788101196},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.426056444644928},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2609984278678894},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.22239288687705994},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.15_suppl.e21019","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.e21019","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.e21019","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3172222552","https://openalex.org/W4389751289","https://openalex.org/W2954624651","https://openalex.org/W3170151675","https://openalex.org/W4221050414","https://openalex.org/W2981342572","https://openalex.org/W4399548395","https://openalex.org/W2892190472","https://openalex.org/W2891839100","https://openalex.org/W2501800173"],"abstract_inverted_index":{"e21019":[0],"Background:":[1],"VEGF":[2],"inhibition":[3],"is":[4,27,33,55,114,196,204,214,219,241,259,269],"suggested":[5],"to":[6,36,40,47,66,122,166,306,316,347,383],"enhance":[7],"innate":[8],"T":[9,19,312],"cell":[10,298,313],"function,":[11],"activate":[12],"dendritic":[13],"cells,":[14,20],"block":[15],"recruitment":[16],"of":[17,71,150,173,321,334,356,381,391],"regulatory":[18],"and":[21,69,74,85,107,116,133,153,201,266,272,296,311,324,329],"decrease":[22],"myeloid-derived":[23],"suppressor":[24],"cells.":[25],"Vorolanib":[26],"a":[28,118,280,284,373],"tyrosine":[29],"kinase":[30],"inhibitor":[31],"that":[32,376],"structurally":[34],"similar":[35],"sunitinib":[37],"but":[38,256],"designed":[39,59],"improve":[41],"safety":[42,68],"without":[43],"compromising":[44],"efficacy.":[45],"Response":[46],"checkpoint":[48],"inhibitors":[49],"in":[50,81,129,222,234,251,263,287,304,309,340],"patients":[51,89,177,237,345,358],"with":[52,92,238,244,283,350,359,369],"thoracic":[53],"tumors":[54],"limited,":[56],"thus":[57],"we":[58,77],"this":[60],"multi-institutional,":[61],"phase":[62],"I/II":[63],"study":[64],"(NCT03583086)":[65],"explore":[67],"efficacy":[70],"combining":[72],"vorolanib":[73,106,335],"nivolumab.":[75,353],"Here":[76],"present":[78],"updated":[79],"results":[80],"the":[82,124,202,208,211,217,235,252,257,264,318,322,325,338,341],"NSCLC,":[83],"thymic,":[84],"SCLC":[86,265],"cohorts,":[87],"including":[88,226,292],"previously":[90],"treated":[91],"single":[93,297,351],"agent":[94,352],"IO.":[95],"Methods:":[96],"The":[97,188,332],"Phase":[98,112],"I":[99],"maximum":[100],"tolerated":[101],"dose":[102],"was":[103],"200":[104],"mg":[105,109],"240":[108],"nivolumab":[110],"q2w.":[111],"II":[113],"ongoing":[115],"uses":[117],"two-stage":[119],"MinMax":[120],"design":[121],"assess":[123],"objective":[125],"response":[126,282,286,382],"rate":[127,191],"(RR)":[128],"SCLC,":[130],"thymic":[131,267,277],"carcinoma,":[132],"three":[134],"NSCLC":[135,209,236,344,357],"cohorts:":[136],"1)":[137],"IO":[138,167,223,342,361],"na\u00efve;":[139],"2)":[140],"primary":[141,253],"refractory,":[142],"defined":[143,157],"as":[144,158],"radiographic":[145],"progression":[146],"<":[147],"12":[148],"weeks":[149,165],"starting":[151],"IO;":[152],"3)":[154],"acquired":[155,239,370],"resistance,":[156],"achieving":[159],"at":[160,363],"least":[161,364],"stable":[162,365],"disease":[163,189],"\u226512":[164],"followed":[168],"by":[169],"progression.":[170],"Results:":[171],"As":[172],"December":[174],"2019,":[175],"37":[176],"had":[178,279,372],"enrolled,":[179],"38%":[180],"female,":[181],"11%":[182],"never":[183],"smokers,":[184],"median":[185],"age":[186],"66.":[187],"control":[190],"(DCR)":[192],"across":[193],"all":[194],"cohorts":[195,268,390],"65%":[197],"(20/31":[198],"evaluable":[199],"patients)":[200],"RR":[203,213,218,233,339],"13%":[205],"(4/31).":[206],"In":[207],"cohort,":[210],"overall":[212],"14%":[215,242],"(3/21);":[216],"33%":[220],"(2/6)":[221],"na\u00efve":[224,343],"patients,":[225],"2":[227],"on":[228],"therapy":[229,384],">":[230],"17":[231],"months.":[232],"resistance":[240,371],"(1/7)":[243],"an":[245],"86%":[246],"(6/7)":[247],"DCR.":[248],"No":[249],"responses":[250],"refractory":[254],"cohort":[255],"DCR":[258,262],"50%":[260,273],"(4/8).":[261],"40%":[270],"(2/5)":[271],"(2/4),":[274],"respectively;":[275],"1":[276,367],"patient":[278,368],"partial":[281],"complete":[285],"target":[288],"lesions.":[289],"Exploratory":[290],"correlatives,":[291],"mass":[293],"cytometry":[294],"analysis":[295],"gene":[299],"expression,":[300],"are":[301],"being":[302],"performed":[303],"order":[305],"understand":[307],"changes":[308],"macrophages":[310],"activation":[314],"markers":[315],"differentiate":[317],"underlying":[319],"biology":[320],"tumor":[323],"microenvironment":[326],"between":[327],"responders":[328],"nonresponders.":[330],"Conclusions:":[331],"addition":[333],"nearly":[336],"doubled":[337],"compared":[346],"historical":[348],"data":[349],"Additionally,":[354],"67%":[355],"prior":[360],"achieved":[362],"disease,":[366],"response.":[374],"Correlatives":[375],"may":[377],"help":[378],"define":[379],"biomarkers":[380],"will":[385],"be":[386],"presented":[387],"among":[388],"different":[389],"patients.":[392],"Clinical":[393],"trial":[394],"information:":[395],"NCT03583086":[396],".":[397]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2020-06-05T00:00:00"}